<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dong X</submitter><funding>Howard Hughes Medical Institute</funding><funding>NIAID NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>NIAMS NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>1645-1662.e7</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9474599</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>55(9)</volume><pubmed_abstract>Healthy skin maintains a diverse microbiome and a potent immune system to fight off infections. Here, we discovered that the epithelial-cell-derived antimicrobial peptides defensins activated orphan G-protein-coupled receptors (GPCRs) Mrgpra2a/b on neutrophils. This signaling axis was required for effective neutrophil-mediated skin immunity and microbiome homeostasis. We generated mutant mouse lines lacking the entire Defensin (Def) gene cluster in keratinocytes or Mrgpra2a/b. Def and Mrgpra2 mutant animals both exhibited skin dysbiosis, with reduced microbial diversity and expansion of Staphylococcus species. Defensins and Mrgpra2 were critical for combating S. aureus infections and the formation of neutrophil abscesses, a hallmark of antibacterial immunity. Activation of Mrgpra2 by defen</pubmed_abstract><journal>Immunity</journal><pubmed_title>Keratinocyte-derived defensins activate neutrophil-specific receptors Mrgpra2a/b to prevent skin dysbiosis and bacterial infection.</pubmed_title><pmcid>PMC9474599</pmcid><funding_grant_id>R01 AR074846</funding_grant_id><funding_grant_id>R37 NS054791</funding_grant_id><funding_grant_id>R01 AI146177</funding_grant_id><funding_grant_id>P30 AR079200</funding_grant_id><funding_grant_id>R21 AI167047</funding_grant_id><funding_grant_id>T32 AR074920</funding_grant_id><funding_grant_id>R01 AR077007</funding_grant_id><funding_grant_id>T32 GM136577</funding_grant_id><funding_grant_id>R01 AR070116</funding_grant_id><funding_grant_id>R01 AR069502</funding_grant_id><funding_grant_id>R01 AR073665</funding_grant_id><pubmed_authors>Youn C</pubmed_authors><pubmed_authors>Goff L</pubmed_authors><pubmed_authors>Lu W</pubmed_authors><pubmed_authors>Dong X</pubmed_authors><pubmed_authors>Sypek EI</pubmed_authors><pubmed_authors>Wang G</pubmed_authors><pubmed_authors>Pundir P</pubmed_authors><pubmed_authors>Garza LA</pubmed_authors><pubmed_authors>Alphonse MP</pubmed_authors><pubmed_authors>Lay M</pubmed_authors><pubmed_authors>Archer NK</pubmed_authors><pubmed_authors>Vasavda C</pubmed_authors><pubmed_authors>Ortines RV</pubmed_authors><pubmed_authors>Limjunyawong N</pubmed_authors><pubmed_authors>Kothari R</pubmed_authors><pubmed_authors>Dikeman D</pubmed_authors><pubmed_authors>Kim BS</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Miller LS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Keratinocyte-derived defensins activate neutrophil-specific receptors Mrgpra2a/b to prevent skin dysbiosis and bacterial infection.</name><description>Healthy skin maintains a diverse microbiome and a potent immune system to fight off infections. Here, we discovered that the epithelial-cell-derived antimicrobial peptides defensins activated orphan G-protein-coupled receptors (GPCRs) Mrgpra2a/b on neutrophils. This signaling axis was required for effective neutrophil-mediated skin immunity and microbiome homeostasis. We generated mutant mouse lines lacking the entire Defensin (Def) gene cluster in keratinocytes or Mrgpra2a/b. Def and Mrgpra2 mutant animals both exhibited skin dysbiosis, with reduced microbial diversity and expansion of Staphylococcus species. Defensins and Mrgpra2 were critical for combating S. aureus infections and the formation of neutrophil abscesses, a hallmark of antibacterial immunity. Activation of Mrgpra2 by defen</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2026-05-28T01:22:38.896Z</modification><creation>2024-11-13T21:39:56.492Z</creation></dates><accession>S-EPMC9474599</accession><cross_references><pubmed>35882236</pubmed><doi>10.1016/j.immuni.2022.06.021</doi></cross_references></HashMap>